Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective

Genes causally involved in human insensitivity to pain provide a unique molecular source of studying the pathophysiology of pain and the development of novel analgesic drugs. The increasing availability of “big data” enables novel research approaches to chronic pain while also requiring novel techni...

Full description

Bibliographic Details
Main Authors: Jörn Lötsch, Catharina Lippmann, Dario Kringel, Alfred Ultsch
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fnmol.2017.00252/full
id doaj-7c8434af2a4343cfb3d44fa9e2f1a35b
record_format Article
spelling doaj-7c8434af2a4343cfb3d44fa9e2f1a35b2020-11-25T00:39:18ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992017-08-011010.3389/fnmol.2017.00252271396Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing PerspectiveJörn Lötsch0Jörn Lötsch1Catharina Lippmann2Dario Kringel3Alfred Ultsch4Institute of Clinical Pharmacology, Goethe-UniversityFrankfurt am Main, GermanyFraunhofer Institute of Molecular Biology and Applied Ecology-Project Group, Translational Medicine and Pharmacology (IME-TMP)Frankfurt am Main, GermanyFraunhofer Institute of Molecular Biology and Applied Ecology-Project Group, Translational Medicine and Pharmacology (IME-TMP)Frankfurt am Main, GermanyInstitute of Clinical Pharmacology, Goethe-UniversityFrankfurt am Main, GermanyDataBionics Research Group, University of MarburgMarburg, GermanyGenes causally involved in human insensitivity to pain provide a unique molecular source of studying the pathophysiology of pain and the development of novel analgesic drugs. The increasing availability of “big data” enables novel research approaches to chronic pain while also requiring novel techniques for data mining and knowledge discovery. We used machine learning to combine the knowledge about n = 20 genes causally involved in human hereditary insensitivity to pain with the knowledge about the functions of thousands of genes. An integrated computational analysis proposed that among the functions of this set of genes, the processes related to nervous system development and to ceramide and sphingosine signaling pathways are particularly important. This is in line with earlier suggestions to use these pathways as therapeutic target in pain. Following identification of the biological processes characterizing hereditary insensitivity to pain, the biological processes were used for a similarity analysis with the functions of n = 4,834 database-queried drugs. Using emergent self-organizing maps, a cluster of n = 22 drugs was identified sharing important functional features with hereditary insensitivity to pain. Several members of this cluster had been implicated in pain in preclinical experiments. Thus, the present concept of machine-learned knowledge discovery for pain research provides biologically plausible results and seems to be suitable for drug discovery by identifying a narrow choice of repurposing candidates, demonstrating that contemporary machine-learned methods offer innovative approaches to knowledge discovery from available evidence.http://journal.frontiersin.org/article/10.3389/fnmol.2017.00252/fulldata sciencecomputational biologypainhumansgenetic variationmachine learning
collection DOAJ
language English
format Article
sources DOAJ
author Jörn Lötsch
Jörn Lötsch
Catharina Lippmann
Dario Kringel
Alfred Ultsch
spellingShingle Jörn Lötsch
Jörn Lötsch
Catharina Lippmann
Dario Kringel
Alfred Ultsch
Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
Frontiers in Molecular Neuroscience
data science
computational biology
pain
humans
genetic variation
machine learning
author_facet Jörn Lötsch
Jörn Lötsch
Catharina Lippmann
Dario Kringel
Alfred Ultsch
author_sort Jörn Lötsch
title Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
title_short Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
title_full Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
title_fullStr Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
title_full_unstemmed Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
title_sort integrated computational analysis of genes associated with human hereditary insensitivity to pain. a drug repurposing perspective
publisher Frontiers Media S.A.
series Frontiers in Molecular Neuroscience
issn 1662-5099
publishDate 2017-08-01
description Genes causally involved in human insensitivity to pain provide a unique molecular source of studying the pathophysiology of pain and the development of novel analgesic drugs. The increasing availability of “big data” enables novel research approaches to chronic pain while also requiring novel techniques for data mining and knowledge discovery. We used machine learning to combine the knowledge about n = 20 genes causally involved in human hereditary insensitivity to pain with the knowledge about the functions of thousands of genes. An integrated computational analysis proposed that among the functions of this set of genes, the processes related to nervous system development and to ceramide and sphingosine signaling pathways are particularly important. This is in line with earlier suggestions to use these pathways as therapeutic target in pain. Following identification of the biological processes characterizing hereditary insensitivity to pain, the biological processes were used for a similarity analysis with the functions of n = 4,834 database-queried drugs. Using emergent self-organizing maps, a cluster of n = 22 drugs was identified sharing important functional features with hereditary insensitivity to pain. Several members of this cluster had been implicated in pain in preclinical experiments. Thus, the present concept of machine-learned knowledge discovery for pain research provides biologically plausible results and seems to be suitable for drug discovery by identifying a narrow choice of repurposing candidates, demonstrating that contemporary machine-learned methods offer innovative approaches to knowledge discovery from available evidence.
topic data science
computational biology
pain
humans
genetic variation
machine learning
url http://journal.frontiersin.org/article/10.3389/fnmol.2017.00252/full
work_keys_str_mv AT jornlotsch integratedcomputationalanalysisofgenesassociatedwithhumanhereditaryinsensitivitytopainadrugrepurposingperspective
AT jornlotsch integratedcomputationalanalysisofgenesassociatedwithhumanhereditaryinsensitivitytopainadrugrepurposingperspective
AT catharinalippmann integratedcomputationalanalysisofgenesassociatedwithhumanhereditaryinsensitivitytopainadrugrepurposingperspective
AT dariokringel integratedcomputationalanalysisofgenesassociatedwithhumanhereditaryinsensitivitytopainadrugrepurposingperspective
AT alfredultsch integratedcomputationalanalysisofgenesassociatedwithhumanhereditaryinsensitivitytopainadrugrepurposingperspective
_version_ 1725294017651933184